Evidence map›Paper›PMID 16919002›Full record

ArticleImmunology2006

Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Ho-Ki Shim, Julie A Musson, Helen M Harper, Hesta V McNeill, Nicola Walker, Helen Flick-Smith, Alexei von Delwig, E Diane Williamson, John H Robinson

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Polymorphism in theFrontiers in immunology · 2019
    Article
  3. Article
  4. Article
  5. Protecting against plague: towards a next-generation vaccine.Clinical and experimental immunology · 2013
    Review
  6. Article
  7. Article
  8. Article
  9. Amino acid and structural variability of Yersinia pestis LcrV protein.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2010
    Article
  10. Article
  11. Article
  12. Immune defense against pneumonic plague.Immunological reviews · 2008
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ho-Ki ShimMusculoskeletal Research Group, Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
Julie A Musson
Helen M Harper
Hesta V McNeill
Nicola Walker
Helen Flick-Smith
Alexei von Delwig
E Diane Williamson
John H Robinson
Newcastle University · GBDefence Science and Technology Laboratory · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We mapped mouse CD4 T-cell epitopes located in three structurally distinct regions of the V antigen of Yersinia pestis. T-cell hybridomas specific for epitopes from each region were generated to study the mechanisms of processing and presentation of V antigen by bone-marrow-derived macrophages. All three epitopes required uptake and/or processing from V antigen as well as presentation to T cells by newly synthesized major histocompatibility complex (MHC) class II molecules over a time period of 3-4 hr. Sensitivity to inhibitors showed a dependence on low pH and cysteine, serine and metalloproteinase, but not aspartic proteinase, activity. The data indicate that immunodominant epitopes from all three structural regions of V antigen were presented preferentially by the classical MHC class II-restricted presentation pathway. The requirement for processing by the co-ordinated activity of several enzyme families is consistent with the buried location of the epitopes in each region of V antigen. Understanding the structure-function relationship of multiple immunodominant epitopes of candidate subunit vaccines is necessary to inform choice of adjuvants for vaccine delivery. In the case of V antigen, adjuvants designed to target it to lysosomes are likely to induce optimal responses to multiple protective T-cell epitopes.

Indexed as

AnimalsAntigen PresentationAntigens, BacterialBone MarrowCD4-Positive T-LymphocytesEpitope MappingEpitopes, T-LymphocyteFemaleHistocompatibility Antigens Class IIImmunodominant EpitopesMacrophagesMiceMice, Inbred StrainsPlague VaccinePore Forming Cytotoxic ProteinsStructure-Activity RelationshipAntigens, BacterialEpitopes, T-LymphocyteHistocompatibility Antigens Class IIImmunodominant EpitopesLcrV protein, YersiniaPlague VaccinePore Forming Cytotoxic Proteins

Identifiers

PMID16919002
PMCPMC1819574
OpenAlexW2086123219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.